Еверолимус Тева

Everolimus Teva is an oral medication used to manage certain types of tumors and organ transplant rejection. It belongs to the class of mTOR inhibitors, supporting immune response regulation. Suitable for patients requiring long-term therapy oversight. Always consult a healthcare provider for personalized use.

Everolimus Teva is primarily used to treat advanced kidney cancer, pancreatic neuroendocrine tumors, and subependymal giant cell astrocytoma. It is also prescribed to prevent organ transplant rejection in kidney and heart transplant patients. This medication helps regulate the immune system to reduce the risk of complications. Patients may use it alongside other therapies as directed.

Everolimus Teva works by inhibiting specific pathways in the body to control cell growth and immune responses. Users may experience improved stability in their condition over time. Common effects include reduced tumor progression or lowered risk of transplant rejection. Individual responses vary based on medical history and treatment goals.

Store Everolimus Teva at room temperature, away from moisture and direct light. Keep the medication in its original packaging until ready to use. Handle with care to avoid contamination or damage. Always follow the handling instructions provided by your pharmacist or healthcare provider to ensure safety.

Everolimus Teva may interact with other medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness. Grapefruit products and certain antibiotics or antifungals may also alter how the drug works. Discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol use should be approached cautiously.